© 2023 MJH Life Sciences and Drug Topics. All rights reserved.
© 2023 MJH Life Sciences™ and Drug Topics. All rights reserved.
January 25, 2023
January 24, 2023
Biosimilars will have limited effect on the oncology drug expenditures, according to IQVIA. Spending on obesity drugs may increase tenfold, depending on guidelines and payer coverage.
January 20, 2023
The approval makes zanubrutinib available to all patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) whether they are newly diagnosed or previously treated.
January 03, 2023
Researcher modeling the cost effectiveness of chimeric antigen receptor T-cell therapy (CAR-T) therapy and antibody conjugate found that they fell short.
January 02, 2023
The COVID-19 pandemic revealed the advantages of treatment that involved fewer in-person office visits, according to recent research.
December 05, 2022
GSK plc has announced positive results for safety and tolerance of Jemperli (dostarlimab; GSK plc) in treating women with endometrial cancer.
November 29, 2022
A confirmatory trial of Tecentriq in urothelial carcinoma failed to meet the co-primary endpoint of overall survival.
November 21, 2022
This is the first FDA-approved ADC for platinum-resistant disease, according to ImmunoGen.
November 14, 2022
As the main course of treatment for cancer-related pain, the use of opioids comes with a number of issues for both patients and prescribers.
Timing of treatment initiation is crucial for patients with cancer.